Wilmington, Delaware
United States
53
2020-07-16
38
2020-09-29
These are the the leading inventors for applications assigned to Astrazeneca Pharmaceuticals LP:
Astrazeneca Pharmaceuticals LP based in Wilmington, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHT
#2 | 2018-12-06 ✅ Patent 10,789,558 granted on 2020-09-29Non-linear systems and methods for destination selection
#3 | 2018-11-22METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHT
#4 | 2018-09-27SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS
#5 | 2016-12-01SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS
#6 | 2016-09-22 ✅ Patent 9,884,092 granted on 2018-02-06Methods for treating diabetes and reducing body weight
#7 | 2016-05-05Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar Solvent
#8 | 2015-08-27EXENDINS TO LOWER CHOLESTEROL AND TRIGLYCERIDES
#9 | 2014-09-04 ✅ Patent 9,453,063 granted on 2016-09-27Hybrid polypeptides with selectable properties
#10 | 2014-09-04GEL COMPOSITIONS
#11 | 2014-08-21 ✅ Patent 9,382,304 granted on 2016-07-05Engineered polypeptides having enhanced duration of action with reduced immunogenicity
#12 | 2014-08-07Amylin Peptides and Derivatives and Uses Thereof
#13 | 2014-07-17TREATMENT OF CARDIAC ARRHYTHMIAS
#14 | 2014-06-12N-TERMINUS CONFORMATIONALLY CONSTRAINED GLP-1 RECEPTOR AGONIST COMPOUNDS
#15 | 2014-05-15PEPTIDE YY AND PEPTIDE YY AGONISTS FOR TREATMENT OF METABOLIC DISORDERS
#16 | 2014-04-17 ✅ Patent 9,593,154 granted on 2017-03-14Engineered polypeptides having enhanced duration of action
#17 | 2014-02-27 ✅ Patent 9,249,181 granted on 2016-02-02C-terminal amidation of polypeptides
#18 | 2014-02-27GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA
#19 | 2014-02-06 ✅ Patent 8,951,962 granted on 2015-02-10Modified exendins and exendin agonists
#20 | 2013-12-12EXENDINS AND EXENDIN AGONIST ANALOGS TO REGULATE GASTROINTESTINAL MOTILITY
#21 | 2013-11-14 ✅ Patent 8,906,849 granted on 2014-12-09Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
#22 | 2013-11-07 ✅ Patent 8,927,687 granted on 2015-01-06Microcrystalline Y receptor agonists
#23 | 2013-08-08HIGHLY SOLUBLE LEPTINS
#24 | 2013-08-01 ✅ Patent 9,133,260 granted on 2015-09-15GIP analog and hybrid polypeptides with selectable properties
#25 | 2013-07-18Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders
#26 | 2013-07-18 ✅ Patent 9,217,022 granted on 2015-12-22GLP-1 receptor agonist compounds having stabilized regions
#27 | 2013-07-04 ✅ Patent 9,034,819 granted on 2015-05-19Method of lowering cholesterol and triglycerides by administering exendins
#28 | 2013-07-04 ✅ Patent 8,906,851 granted on 2014-12-09Method for treating diabetes
#29 | 2013-05-30 ✅ Patent 8,895,498 granted on 2014-11-25GIP and exendin hybrid polypeptides
#30 | 2013-04-11 ✅ Patent 8,603,761 granted on 2013-12-10GLP-1 receptor agonist bioassay
#31 | 2012-11-29 ✅ Patent 8,551,947 granted on 2013-10-08Treatment of hibernating myocardium with an exendin peptide
#32 | 2012-11-22 ✅ Patent 8,481,490 granted on 2013-07-09Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis
#33 | 2012-08-02 ✅ Patent 8,598,120 granted on 2013-12-03Methods for treatment using amylin family peptides
#34 | 2012-05-31 ✅ Patent 8,445,647 granted on 2013-05-21Modified exendins and exendin agonists
#35 | 2012-03-01 ✅ Patent 8,748,375 granted on 2014-06-10Methods for affecting body composition using amylin agonists
#36 | 2012-02-23 ✅ Patent 8,642,544 granted on 2014-02-04N-terminus conformationally constrained GLP-1 receptor agonist compounds
#37 | 2011-11-24 ✅ Patent 8,389,477 granted on 2013-03-05Amylin and amylin agonists for treating psychiatric diseases and disorders
#38 | 2011-09-01 ✅ Patent 8,895,033 granted on 2014-11-25Sustained release formulations using non-aqueous carriers
#39 | 2011-08-11 ✅ Patent 8,759,291 granted on 2014-06-24Methods of treatment using exendin peptides or GLP-1 peptides
#40 | 2011-07-21 ✅ Patent 8,389,473 granted on 2013-03-05Treatment of cardiac arrhythmias
#41 | 2011-06-09 ✅ Patent 8,497,240 granted on 2013-07-30DPP-IV resistant GIP hybrid polypeptides with selectable properties
#42 | 2011-04-28 ✅ Patent 8,329,419 granted on 2012-12-11GLP-1 receptor agonist bioassays
#43 | 2010-11-25 ✅ Patent 8,636,689 granted on 2014-01-28Pen injection device and method of using same
#44 | 2010-11-18 ✅ Patent 8,759,295 granted on 2014-06-24Peptide-peptidase inhibitor conjugates and methods of using same
#45 | 2010-11-11 ✅ Patent 8,598,314 granted on 2013-12-03Peptide-peptidase-inhibitor conjugates and methods of making and using same
#46 | 2010-08-19 ✅ Patent 8,790,314 granted on 2014-07-29Drug delivery device
#47 | 2010-06-10 ✅ Patent 8,501,693 granted on 2013-08-06Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen
#48 | 2010-04-22 ✅ Patent 8,426,361 granted on 2013-04-23Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
#49 | 2010-04-15 ✅ Patent 9,248,240 granted on 2016-02-02Formulation delivery device
#50 | 2009-12-17 ✅ Patent 8,389,472 granted on 2013-03-05Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
#51 | 2009-05-28 ✅ Patent 8,946,149 granted on 2015-02-03Use of exendin and analogs thereof to delay or prevent cardiac remodeling
#52 | 2008-08-28 ✅ Patent 8,394,765 granted on 2013-03-12Methods of treating obesity with two different anti-obesity agents
#53 | 2006-05-04 ✅ Patent 8,603,969 granted on 2013-12-10Pancreatic polypeptide family motifs and polypeptides comprising the same
Also check out AstraZeneca Pharmaceuticals LP's (Wilmington, United States) applicant profile with 12 patent applications submitted.
29094 ⎘